SEC Form 4 · accession 0001569706-18-000002
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Averback
Officer — CEO · Director · 10% Owner
Period of report
Oct 29, 2018
Accepted (ET)
Nov 6, 2018 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted common | Oct 29, 2018 | S | 1,687,600 | $2.50 | D | 21,643,948 | D |
Table II — derivative securities
No Table II lines on this filing.